These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26304429)

  • 1. Bioavailability and biodistribution of nanodelivered lutein.
    Kamil A; Smith DE; Blumberg JB; Astete C; Sabliov C; Oliver Chen CY
    Food Chem; 2016 Feb; 192():915-23. PubMed ID: 26304429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Poly (Lactic-co-Glycolic Acid)-Polyethylene Glycol Nanocapsules: An Efficient Carrier for Improved Solubility, Bioavailability, and Anticancer Property of Lutein.
    Arunkumar R; Prashanth KVH; Manabe Y; Hirata T; Sugawara T; Dharmesh SM; Baskaran V
    J Pharm Sci; 2015 Jun; 104(6):2085-2093. PubMed ID: 25824524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly (D, L-lactide-co-glycolide)-phospholipid nanocarrier for efficient delivery of macular pigment lutein: absorption pharmacokinetics in mice and antiproliferative effect in Hep G2 cells.
    Ranganathan A; Manabe Y; Sugawara T; Hirata T; Shivanna N; Baskaran V
    Drug Deliv Transl Res; 2019 Feb; 9(1):178-191. PubMed ID: 30284121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
    Harigae T; Nakagawa K; Miyazawa T; Inoue N; Kimura F; Ikeda I; Miyazawa T
    Int J Nanomedicine; 2016; 11():3009-22. PubMed ID: 27418823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of chitosan nanoparticles with phosphatidylcholine for improved sustain release, basolateral secretion, and transport of lutein in Caco-2 cells.
    Shwetha HJ; Shilpa S; Mukherjee MB; Ambedkar R; Raichur AM; Lakshminarayana R
    Int J Biol Macromol; 2020 Nov; 163():2224-2235. PubMed ID: 32918957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the bioavailability of stevioside-encapsulized lutein and its mechanism.
    Dai Z; Song J; Chen Y; Feng L; Xu Y; Li D; Wu C; Zhang Z; Liu J
    Food Chem; 2021 Aug; 354():129528. PubMed ID: 33756320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of lutein-loaded SNEDDS for enhanced absorption in Caco-2 cells.
    Niamprem P; Rujivipat S; Tiyaboonchai W
    Pharm Dev Technol; 2014 Sep; 19(6):735-42. PubMed ID: 23985012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-oleic acid-sodium alginate a hybrid nanocarrier as an efficient delivery system for enhancement of lutein stability and bioavailability.
    Toragall V; Jayapala N; Vallikannan B
    Int J Biol Macromol; 2020 May; 150():578-594. PubMed ID: 32057885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
    Bairwa K; Jachak SM
    J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zein-derived peptides as nanocarriers to increase the water solubility and stability of lutein.
    Jiao Y; Zheng X; Chang Y; Li D; Sun X; Liu X
    Food Funct; 2018 Jan; 9(1):117-123. PubMed ID: 29336438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
    Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
    Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential.
    Singh G; Pai RS
    Expert Opin Drug Deliv; 2014 May; 11(5):647-59. PubMed ID: 24661109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.